TruBridge Inc(TBRG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 86.66 | EPS (ttm) | 0.3 | Insider Own | 0.35% | Shs Outstand | 15.0M | Perf Week | - |
| Market Cap | 0.39B | Forward P/E | 8.89 | EPS next Y | 10.9% | Insider Trans | - | Shs Float | 14.9M | Perf Month | 0.42% |
| Enterprise Value | 0.53B | PEG | - | EPS next Q | 0.61 | Inst Own | 58.94% | Short Float | 3.67% | Perf Quarter | 14.69% |
| Income | 0.00B | P/S | 1.14 | EPS this Y | - | Inst Trans | -7.94% | Short Ratio | 1.58 | Perf Half Y | 30.16% |
| Sales | 0.35B | P/B | 2.19 | EPS next 5Y | - | ROA | 1.07% | Short Interest | 0.55M | Perf YTD | 18.89% |
| Book/sh | 11.99 | P/C | 11.11 | EPS past 3/5Y | -35.52% -21.66% | ROE | 2.46% | 52W High | -1.02% ($26.51) | Perf Year | 14.14% |
| Cash/sh | 2.36 | P/FCF | 8.82 | Sales past 3/5Y | 5.84% 5.57% | ROIC | 1.25% | 52W Low | 89.05% ($13.88) | Perf 3Y | 6.41% |
| Dividend Est. | - | EV/EBITDA | 9.11 | EPS Y/Y TTM | 122.37% | Gross Margin | 45.49% | Volatility(W/M) | 0.11% 0.16% | Perf 5Y | -16.75% |
| Dividend TTM | - | EV/Sales | 1.52 | Sales Y/Y TTM | 0.81% | Oper. Margin | 8.98% | ATR (14) | 0.07 | Perf 10Y | -35.5% |
| Dividend Ex-Date | - | Quick Ratio | 1.77 | EPS Q/Q | 9.74% | Profit Margin | 1.24% | RSI (14) | 79.09 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.78 | Sales Q/Q | -1.07% | SMA20 | 0.32% ($26.16) | Beta | 1.29 | Target Price | $26.25 |
| Payout | - | Debt/Eq | 0.94 | Earnings | 2026/5/8 | SMA50 | 0.97% ($25.99) | Rel Volume | 0 | Prev Close | $26.24 |
| Employees | 3500 | LT Debt/Eq | 0.91 | EPS/Sales Surpr. | -6.23% -8.64% | SMA200 | 21.38% ($21.62) | Avg Volume(3M) | 0.35M | Price | $26.24 |
| IPO | 2002/5/21 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
🏥 TrueBridge (TBRG) is a healthcare IT company whose primary customers are small- to mid-sized and rural hospitals. It offers a combination of healthcare revenue cycle management services and patient care solutions such as electronic medical records, and has built a strong position in the resource-constrained hospital market that larger competitors tend to overlook. The business is characterized by a high proportion of recurring subscription and services revenue, which provides a stable cash flow profile.
Over the past 1 year, on the higher side
1% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
TBRG earns at a steady pace
Of every $100 in sales, $8.98 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +0.0% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $911. Peers typically go for $1,255. Compared with its own 3-year average, it is 220% pricier now.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -16.8%. The S&P 500 did +53% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 58.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #21 of 41 in the industry
Based on market cap of $394M.
FAQ
TBRG belongs to the Healthcare sector and operates in the Health Information Services industry.
The market cap of TBRG is approximately $394M, ranking 3,412 within its sector.
TBRG has a P/E ratio of approximately 86.7x, which can be used to assess its valuation relative to the Healthcare sector average.
TBRG has recorded a 52-week high of $26.51 and a low of $13.88.